IMRAIMARA Inc.
14.59USD0.00%Mkt Cap: —P/E: —14d ago
The manager seeks to achieve these investment objectives through the use of a synthetic covered call strategy. The manager seeks to provide its synthetic exposure to the price return of MARA through the purchase and sale…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)—
Revenue/Share—
Last Price14.59 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)—
EPS (Forward)—
52W Range
11.999% of range42.32
52W High42.32 USD
52W Low11.99 USD
Profitability
Gross Margin—
Oper. Margin—
EBITDA Margin—
Profit Margin—
ROE—
ROA—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield37.89%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float—
Insiders—
Institutions—
Technical
SMA 5015.94 (-8.5%)
SMA 20016.48 (-11.5%)
Beta—
S&P 52W Chg—
Avg Vol (30d)2.15K
Avg Vol (10d)1.56K
Technical Indicators
RSI (14)37.4
MACD-0.4024
MACD Signal-0.4830
MACD Hist.+0.0806
BB Upper15.58 USD
BB Middle14.69 USD
BB Lower13.80 USD
BB Width12.08%
ATR (14)0.2039 USD
Vol Ratio (20d)0.00x